Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Filed Nov 18, 2013 · 10-Q · 49 days after period end · 0001514955-13-000030
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $10.83K | $10.83K | $0.00 |
| Net Income | $190.00 | $2.40K | -$4.01K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 18, 2013 · 49 d after period end
